Aspect Biosystems
Series B
€115M
Total Raised
€196M
Investors
Dimension Capital, Innovate BC, JDRF T1D Fund +5 more
Insights
Operating at the intersection of biotechnology, life science and AI, Aspect Biosystems develops bioprinted tissue therapeutics designed to change how diseases are treated. The team in Vancouver applies advanced 3D bioprinting techniques to build living tissues for research and therapeutic use. Backed by venture firms like Dimension Capital and Pallasite Ventures as well as strategic investors such as Novo Nordisk and the JDRF T1D Fund, the company seeks to address unmet medical needs through engineered tissue models.
Careers at Aspect Biosystems
Similar Companies
JumpArtificial Intelligence (AI), Financial Services, FinTech, Generative AI, SaaS, Wealth Management · Salt Lake City, Utah, United States, North America
OuttakeArtificial Intelligence (AI), Cyber Security, Machine Learning · Brooklyn, New York, United States, North America
GoodfireArtificial Intelligence (AI), Generative AI, Information Technology · San Francisco, California, United States, North America
Northwood SpaceAerospace, Hardware, Satellite Communication · Torrance, California, United States, North America
ZocksArtificial Intelligence (AI), Enterprise Software, Financial Services, Software · San Francisco, California, United States, North America
VulnCheckArtificial Intelligence (AI), Cyber Security, Information Technology, Network Security · Lexington, Massachusetts, United States, North America